NFKB1 and lung carcinoma: Recent studies have shown that Sotetsuflavone can inhibit the epithelial-mesenchymal transition, invasion, and metastasis of lung cancer cells in A549 cells through the TNF-α/NF-κB pathway (Wang et al., 2018).